-
Je něco špatně v tomto záznamu ?
Alternative reliable method for cytochrome P450 2D6 poor metabolizers genotyping
E. Pindurová, A. Zourková, J. Zrůstová, J. Juřica, A. Pavelka,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS9676
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
Medline Complete (EBSCOhost) od 2011-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem
Odkazy
PubMed
22367691
DOI
10.1007/s12033-012-9510-2
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- běloši genetika MeSH
- cytochrom P-450 CYP2D6 genetika metabolismus MeSH
- DNA primery genetika MeSH
- frekvence genu MeSH
- genotypizační techniky metody MeSH
- heterozygot MeSH
- homozygot MeSH
- jednonukleotidový polymorfismus MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- lidé MeSH
- senzitivita a specificita MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
High-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons has been described as a fast, cheap, and reliable closed-tube method of genotyping with no need for labeled primers or labeled probes. We adapted this melting analysis assay for the detection of the most common nonfunctional alleles of cytochrome P-450 (CYP) 2D6 in the Caucasian population that affect the metabolism of many commonly used drugs. We used this method to genotype 91 patients under paroxetine therapy. The presence and the constitution of the most common single-nucleotide polymorphisms (1846G>A, 2988G>A, 100C>T, 2549delA, 2615_2617delAAG, and 1707delT) in poor and intermediate metabolizers from the Caucasian population were detected in short amplicons (≤148 bp). After fluorescence normalization, the wild-type, homozygous, and heterozygous samples were easily distinguishable from each other by their specific melting curve shape. A total of 92.6% of the 1846G>A heterozygotes, 96% of the 100C>T heterozygotes, and 100% of the 2988G>A, 2549delA, 2615_2617delAAG, and 1707delT heterozygotes have been correctly distinguished from the wild types. One hundred percent of all the homozygotes in this group of patients have been detected without any error. HRM of short amplicons is a simple tool for effective, rapid, and reliable CYP2D6 genotyping that does not require real-time PCR, labeled probes, processing or any separations after PCR. The reaction is performed in a closed-tube system and is highly specific and sensitive. We proved that this technique is highly reliable for use in routine diagnostics.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024465
- 003
- CZ-PrNML
- 005
- 20140904125632.0
- 007
- ta
- 008
- 130703s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12033-012-9510-2 $2 doi
- 035 __
- $a (PubMed)22367691
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pindurová, E $u Department of Applied Neuroscience, Faculty of Medicine, Central European Institute of Technology (CEITEC), Brno, Czech Republic. noprecejaef@seznam.cz
- 245 10
- $a Alternative reliable method for cytochrome P450 2D6 poor metabolizers genotyping / $c E. Pindurová, A. Zourková, J. Zrůstová, J. Juřica, A. Pavelka,
- 520 9_
- $a High-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons has been described as a fast, cheap, and reliable closed-tube method of genotyping with no need for labeled primers or labeled probes. We adapted this melting analysis assay for the detection of the most common nonfunctional alleles of cytochrome P-450 (CYP) 2D6 in the Caucasian population that affect the metabolism of many commonly used drugs. We used this method to genotype 91 patients under paroxetine therapy. The presence and the constitution of the most common single-nucleotide polymorphisms (1846G>A, 2988G>A, 100C>T, 2549delA, 2615_2617delAAG, and 1707delT) in poor and intermediate metabolizers from the Caucasian population were detected in short amplicons (≤148 bp). After fluorescence normalization, the wild-type, homozygous, and heterozygous samples were easily distinguishable from each other by their specific melting curve shape. A total of 92.6% of the 1846G>A heterozygotes, 96% of the 100C>T heterozygotes, and 100% of the 2988G>A, 2549delA, 2615_2617delAAG, and 1707delT heterozygotes have been correctly distinguished from the wild types. One hundred percent of all the homozygotes in this group of patients have been detected without any error. HRM of short amplicons is a simple tool for effective, rapid, and reliable CYP2D6 genotyping that does not require real-time PCR, labeled probes, processing or any separations after PCR. The reaction is performed in a closed-tube system and is highly specific and sensitive. We proved that this technique is highly reliable for use in routine diagnostics.
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a cytochrom P-450 CYP2D6 $x genetika $x metabolismus $7 D019389
- 650 _2
- $a DNA primery $x genetika $7 D017931
- 650 _2
- $a běloši $x genetika $7 D044465
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genotypizační techniky $x metody $7 D060005
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a homozygot $7 D006720
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zourková, A $u -
- 700 1_
- $a Zrůstová, J $u -
- 700 1_
- $a Juřica, J $u -
- 700 1_
- $a Pavelka, A $u -
- 773 0_
- $w MED00180392 $t Molecular biotechnology $x 1559-0305 $g Roč. 53, č. 1 (2013), s. 29-40
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22367691 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20140904130027 $b ABA008
- 999 __
- $a ok $b bmc $g 988145 $s 822845
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 53 $c 1 $d 29-40 $i 1559-0305 $m Molecular biotechnology $n Mol Biotechnol $x MED00180392
- GRA __
- $a NS9676 $p MZ0
- LZP __
- $a Pubmed-20130703